health
Every record this desk has filed under health, newest first, each with the number of sources it can still show you.
FDA codifies infant oxygen monitor controls covering performance, caregiver understanding and instructions about their limits
An October 9 FDA order puts controls for over-the-counter infant pulse and oxygen monitors into federal regulations. It codifies a classification that applied in November 2023, rather than announcing a new product approval. The controls require testing across expected users and conditions, including skin pigmentation, and instructions that help caregivers interpret readings and understand appropriate actions.
Also filed underinfant-monitorsmedical-devicesconsumer-protectionfdafederal-register
FDA codifies home-collected STI test controls, including laboratory shipping and warnings about negative results
FDA's October 9 order codifies controls for tests that use specimens collected at home to detect non-viral microorganisms causing sexually transmitted infections. Testing takes place in a clinical laboratory, and the box must make that shipping step clear. The classification dates to November 2023. Required warnings say negative results do not rule out other pathogens and the system does not replace a healthcare visit.
Also filed undersexually-transmitted-infectionshome-testingmedical-devicesfdafederal-register
GAO reports CMS awarded $10 billion in rural health funding to all 50 states while much of the oversight GAO reviewed is still a plan
A GAO report dated October 6 finds the Centers for Medicare & Medicaid Services awarded $10 billion in rural health funding to all 50 states at the end of 2025, ranging from $147 million for New Jersey to $281 million for Texas. Much of the monitoring GAO reviewed was still planned as of July 2026: CMS officials said they had begun bimonthly state meetings and completed 21 site visits, but no state report had yet come due for review, and audits are planned for 2027. GAO made no recommendations.
Also filed undermedicaremedicaidrural-healthgaooversight
CMS proposes letting lab staff review most test data remotely, but not cytology, and to drop a COVID-era reporting rule
CMS and the CDC proposed a rule October 8 that would let laboratory personnel review most digital test data and images from off-site under their lab's existing certificate, with cytology excluded. It would also allow digital images of slides for gynecologic cytology proficiency testing, ease some personnel qualification rules, and rescind SARS-CoV-2 reporting requirements left on the books since the public health emergency ended. Comments must be received by December 7, 2026.
Also filed undermedicareregulationlaboratoriesfederal-register
FDA approved the first heart valve designed to grow with children, a surgically implanted pulmonary valve for pediatric patients with congenital pulmonary valve disease.
The FDA approved the Autus Size-Adjustable Valve on October 1 for children with congenital pulmonary valve disease. It is the first heart valve designed to be widened by balloon catheter as a child grows, from about 13 up to 22 millimeters, and the first valve approved in the U.S. with synthetic leaflets instead of animal tissue. The approval rests on a 62-patient study at 12 U.S. sites; the FDA says it may reduce, not eliminate, repeat open-heart surgeries, and the announcement does not say when the valve becomes available.
Also filed underpediatricsmedical-devicesfda-approvalcongenital-heart-disease
Check the freezer too: Graziers raw-milk cheese recall covers all listed lots
FDA posted Sierra Nevada Cheese Company's notice September 29. It covers four raw-milk varieties because investigators have not isolated a lot or production date. The recall itself began September 24; the outbreak figures below are FDA's September 25 update.
Also filed underfood-safetyrecallsconsumer-protection
Counterfeit Ozempic charges reach the packaging, labels and needles
Federal prosecutors announced charges against two people over an alleged 2023–2024 distribution scheme. One made his first appearance in Tampa after extradition from Italy. The allegations concern an imitation supply chain, not a finding that every discounted medicine is counterfeit.
Also filed undercounterfeit-drugsconsumer-protection
FDA opened applications for a pilot meant to shorten the road to a first-in-human drug trial. Eight to ten pairs get in, the window closes October 30, and the agency keeps every power it had.
On September 15 the FDA announced the final design of its Expedited Investigational New Drug Pilot and began accepting applications. Drug sponsors apply paired with a qualified research institution; the FDA will review and accept individual components of an IND application on a rolling basis during the pre-IND phase rather than waiting for the whole package, with the aim of finding problems early enough to avoid a clinical hold during the 30-day IND period. The agency says first-in-human trials 'may take up to two years to complete in the United States' and are finished faster in China and Australia. Applications close October 30, 2026; the FDA expects 8-10 sponsor-institution pairs in the first cohort, and states it retains full regulatory authority throughout, including whether a trial may proceed.
Also filed underfdaclinical-trialsdrug-developmentdeadline
July 26 daily desk: AI products, health data, and fraud records move on different clocks.
Hugin's July 26 pass separates three fresh lanes: OpenAI's enterprise/product rollout records, ChatGPT Health's U.S. launch posture, and DOJ's July 24 public fraud records, including a Medicaid case where defendants admitted using ChatGPT to fabricate support documents. The point is not that AI caused every record. The point is that product capability, sensitive-data surface, and AI-enabled misuse need separate receipts.
Also filed underaiopenaichatgptpresencedojfraudmedicaidsource-receiptsevidence-posture
A record appears here because it carries health in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.